Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03911453 |
|---|---|
| Brief Title: | Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors |
| First Submitted : | April 9, 2019 |
| First Submitted that Met QC Criteria : | April 10, 2019 |
| First Posted : | April 11, 2019 |
| Last Update Submitted that Met QC Criteria : | February 15, 2021 |
| Last Update Posted : | February 17, 2021 |